Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy

Mostrar otras versiones (1)

An excessive immune response during coronavirus disease (COVID-19) can induce cytokine release syndrome (CRS), which is associated with life-threatening complications and disease progression. This retrospective study evaluated the clinical characteristics of severe CRS (sCRS, grade 3–4) induced by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ruimin, Zhao, Houli, Wang, Yiyun, Chen, Yu, Cai, Hongliu, Hu, Yongxian, Wei, Guoqing, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498115/
https://www.ncbi.nlm.nih.gov/pubmed/32943758
http://dx.doi.org/10.1038/s41409-020-01060-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498115/
https://www.ncbi.nlm.nih.gov/pubmed/32943758
http://dx.doi.org/10.1038/s41409-020-01060-5

Ejemplares similares